Jul 5, 2024 | Biosimilars, Cost Savings, Humira, MedBen Rx, News, Rx Costs, Savings
The Food and Drug Administration is considering a change to its biosimilar policy that would greatly speed up their approval process – which, if enacted, would be a big win for MedBen Rx clients who are already reducing their prescription drug spend through...
Apr 29, 2024 | Access solutions, Alternative Reimbursement Strategies, Benefits preservation, Cost Savings, Direct-to-Employer Contracting, MedBen Rx, Savings, Spousal limitations
It’s hardly shocking that in a new national benefits employer survey, 29 percent of respondents cited “reducing costs” as the most important consideration for employee benefit decisions. However, the steps some employers are using to lower their...
Apr 16, 2024 | Biosimilars, Cost Savings, Drug costs, Humira, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings
Last year, MedBen Rx announced a new program that would enable clients to purchase Idacio, a biosimilar version of the anti-inflammatory therapy Humira – a drug that typically costs between $6,000 and $12,000 per month depending on the dose – for under $1,000 per...
Apr 15, 2024 | Alternative Reimbursement Strategies, Benchmarks, Cost Savings, Fair market reimbursement, Savings
At the Private Employer Roundtable on April 11, Regional Sales Director Brooke Hupp highlighted alternative reimbursement strategies that reduce health care costs, including MedBen’s newest strategy, Fair Market Reimbursement (FMR). This innovative approach...
Apr 2, 2024 | Case Studies, Claims, Claims Management, Claims negotiation, Cost Savings, Forensic claims review, Savings
Claim savings don’t have to end with the PPO network discount. With MedBen’s forensic claims review services, savings are produced after network discounts are applied, but before claims are paid. As the case study below shows, while PPO network discounts alone...
Apr 1, 2024 | Benefits preservation, Comparative Effectiveness, Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Specialty Drugs, Transparency
Employers are turning away from the “big three” pharmacy benefits managers to other PBMs that offer greater transparency and lower costs, says Wharton professor of health care management Lawton Robert Burns. As one of those alternatives, MedBen Rx is...
